🇺🇸
SEOUL, South Korea and COLOGNE, Germany, Oct. 22, 2026 /PRNewswire/ — ImmunoForge Co., Ltd., a clinical-stage biopharmaceutical company dedicated to developing transformative therapies for rare and intractable diseases, today announced that its executive management team will participate…
Source: prnewswire
Country: United States